Current trends in pharmaceutical industry: Post -CoVid-19 pandemic effects P3
December 10, 20256
Author and Source: Sranford University
Photo / Image Source: Unsplash,
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright N
Background:
Post-pandemic challenges:
Increased demand:
The pharmaceutical industries have been tumbled by the CoVid-19 pandemic of its rapid spread and indefinite treatment. The increased need for pharmaceuticals have been moved towards research in developing treatment strategies and drug supply during the crisis time to meet the increased demand [7]. The overspread of the pandemic, overbuying due to panic and supply chain shortage have increased the demand of medicines. Panic buying and stocking of drugs for the treatment of chronic ailments by the general public was reported worldwide [8, 9]. There was a significant increase in the demand for medications treating chronic conditions such as hypertension, diabetes and mental health disorders. It has been reported that countries like Australia and Germany effectively managed this surge through stock regulation and supply-demand balancing [10]. However, the global pharmaceutical industry faced significant obstacles with the disrupted supply of active pharmaceutical ingredients (APIs) from the primary suppliers, China and India. This commotion, coupled with increased demand, led to price hikes for essential drugs such as amoxicillin, ceftriaxone and ciprofloxacin [10, 11]. The other common drugs added to the demand list by the Food and Drug Association (FDA) were the covid related medications like hydroxyl-chloroquine, chloroquine, azithromycin, dopamine, dobutamine, fentanyl, heparin, midazolam, propofol, dexmedetomidine [12]. Increased demand for drugs from 100% to 700% was noted for respiratory treatments, sedatives and pain treatments. This is due to the disruption in the supply and transport of raw materials required for production [7]. Increased demand created an increase in price of the essential drugs during the pandemic. The cost increase was reflected by antibiotics like amoxicillin, potassium clavulanate, ceftriaxone potassium sterile, meropenam, vancomycin, gentamycin and ciprofloxacin. Therefore, the world's demand for pharmaceuticals dominated the domestic consumption of the drugs which was restricted by the Indian Pharmaceutical Alliance (IPA). As a result, drug demand affected the Indian trade and was reported to be about 10-15% which reached 50% for some pharmaceuticals [7].
Supply chain deficiency:
Long before the pandemic, a coordinated approach to reporting medicine issues and shortages was set up, which reported the risks of supply chain vulnerabilities [13]. During the pandemic, supply chain shortages increased as hospitalizations led to shortages of both CoVid-19 and non - CoVid-19 medications. Workforce shortages and transportation disruptions further strained the supply chain, particularly in countries like India, where lockdowns severely impacted production and distribution capabilities [10].
e.
Do you have a major health concern? How do you stay fit and healthy? How do you keep your family healthy?
Share the wealth of health with your friends and family by sharing this article with 3 people today.
If this article was helpful to you, donate to the Shidonna Raven Garden and Cook E-Magazine Today. Thank you in advance.
Comments